IJDVL Home  
 

STUDIES
[Download PDF]  
Year : 1995  |  Volume : 61  |  Issue : 5  |  Page : 265-267

Evaluation of H2-Receptor antagonists in chronic idiopathic urticaria

YC Minocha, KB Minocha, VK Sood, A Dogra 
 Department of Dermatology, Venereology and Pharmacology, Dayanand Medical College and Hospital, Ludhiana-141001, India

Correspondence Address:
Y C Minocha
Department of Dermatology, Venereology and Pharmacology, Dayanand Medical College and Hospital, Ludhiana-141001
India

H1-antagonist (hydroxyzine hydrochloride) in dosage of 10 mg-25 mg thrice a day failed to elicit satisfactory response in 60 out of 170 patients of chronic idiopathic urticaria. Additional administration of H2-antagonist (cimetidine) in dosage of 200 mg four times a day, in patients not responding earlier to H1-antagonist alones exhibited moderate to good improvement of various parameters of urticaria in approximately 85% patients.


How to cite this article:
Minocha Y C, Minocha K B, Sood V K, Dogra A. Evaluation of H2-Receptor antagonists in chronic idiopathic urticaria.Indian J Dermatol Venereol Leprol 1995;61:265-267


How to cite this URL:
Minocha Y C, Minocha K B, Sood V K, Dogra A. Evaluation of H2-Receptor antagonists in chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol [serial online] 1995 [cited 2020 Jul 14 ];61:265-267
Available from: http://www.ijdvl.com/article.asp?issn=0378-6323;year=1995;volume=61;issue=5;spage=265;epage=267;aulast=Minocha;type=0


 

Tuesday, July 14, 2020
 Site Map | Home | Contact Us | Feedback | Copyright and disclaimer